Robotic Extended Pelvic Lymphadenectomy for Intermediate- and High-Risk Prostate Cancer

被引:50
|
作者
Yuh, Bertram E. [1 ]
Ruel, Nora H. [1 ]
Mejia, Rosa [1 ]
Wilson, Chelsea M. [1 ]
Wilson, Timothy G. [1 ]
机构
[1] City Hope Natl Canc Ctr, Duarte, CA 90017 USA
关键词
Pelvic lymphadenectomy; Robotics; Positive lymph nodes; Prostate Cancer; LYMPH-NODE DISSECTION; RADICAL PROSTATECTOMY; IMPACT; METASTASES; MEN; YIELD;
D O I
10.1016/j.eururo.2012.01.048
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Accurate staging of prostate cancer is enhanced by a thorough evaluation of the pelvic lymph nodes. Limited data are available regarding robotic extended pelvic lymphadenectomy (PLA) in this setting. Objective: Analyze our experience performing robotic extended PLA. Design, setting, and participants: A total of 143 consecutive men with intermediate-or high-risk clinically localized adenocarcinoma of the prostate underwent robotic extended PLA and radical prostatectomy between September 2010 and November 2011 by a single surgeon. Surgical procedure: Lymph node packets were sent separately from bilateral common, external, and internal iliacs, obturators, node of Cloquet, and anterior prostatic fat. Measurements: Descriptive statistics were used to summarize lymph node yields and positive nodes. Clinical variables were examined in logistic regression models to predict lymph node positivity. Results and limitations: Median lymph node yield was 20 (range: 9-65, interquartile range: 15-25). Eighteen patients (13%) were found to have metastatic prostate cancer in the lymph nodes. The mean number of positive nodes foundwas 2.9 (range: 1-11). In 14 of 18 node-positive patients (78%), the extent of nodal invasion was outside the boundaries of a limited PLA. For four patients with positive nodes (22%), prostate biopsy predicted unilateral disease but PLA revealed contralateral positive lymph nodes. A total of 82% of patients experienced no complications, and most Clavien grade 1-2 complications consisted of anastomotic leakage, urinary retention, ileus, and lymphocele. Only 4% of patients experienced a grade 3 complication. Under multivariate regression analysis, prostate-specific antigen (PSA), clinical stage, and maximum biopsy core tumor volume were identified as significant predictors of finding positive pelvic lymph nodes (area under the curve: 91%). The main limitations include short follow-up and lack of randomization. Conclusions: Robotic extended bilateral PLA for prostate cancer up to the common iliac bifurcation increases nodal yield and positive nodal rate and can be performed safely. PSA, clinical stage, and maximum biopsy core volume are predictors for lymph node invasion. Long-term follow-up is needed to evaluate for therapeutic benefit. (C) 2012 European Association of Urology. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:1004 / 1010
页数:7
相关论文
共 50 条
  • [21] Brachytherapy Increased use in patients with intermediate- and high-risk prostate cancers
    Ali, Sanna
    Esper, Peg
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2021, 25 (03) : 321 - 328
  • [22] Is Clinical Stage T2c Prostate Cancer an Intermediate- or High-Risk Disease?
    Klaassen, Zachary
    Singh, Abhay A.
    Howard, Lauren E.
    Feng, Zhaoyong
    Trock, Bruce
    Terris, Martha K.
    Aronson, William J.
    Cooperberg, Matthew R.
    Amling, Christopher L.
    Kane, Christopher J.
    Partin, Alan
    Han, Misop
    Freedland, Stephen J.
    CANCER, 2015, 121 (09) : 1414 - 1421
  • [23] A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
    Armstrong, Andrew J.
    Netto, George J.
    Rudek, Michelle A.
    Halabi, Susan
    Wood, David P.
    Creel, Patricia A.
    Mundy, Kelly
    Davis, S. Lindsay
    Wang, Ting
    Albadine, Roula
    Schultz, Luciana
    Partin, Alan W.
    Jimeno, Antonio
    Fedor, Helen
    Febbo, Phillip G.
    George, Daniel J.
    Gurganus, Robin
    De Marzo, Angelo M.
    Carducci, Michael A.
    CLINICAL CANCER RESEARCH, 2010, 16 (11) : 3057 - 3066
  • [24] Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study
    Kubo, Nobuteru
    Kawamura, Hidemasa
    Oike, Takahiro
    Sato, Hiro
    Iwanaga, Mototaro
    Mizukami, Tatsuji
    Adachi, Akiko
    Matsui, Hiroshi
    Ito, Kazuto
    Suzuki, Kazuhiro
    Nakano, Takashi
    IN VIVO, 2019, 33 (04): : 1235 - 1241
  • [25] TOXICITY ASSESSMENT OF PELVIC INTENSITY-MODULATED RADIOTHERAPY WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO PROSTATE FOR INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER
    McCammon, Robert
    Rusthoven, Kyle E.
    Kavanagh, Brian
    Newell, Sherri
    Newman, Francis
    Raben, David
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02): : 413 - 420
  • [26] The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancer
    Siech, Carolin
    Wenzel, Mike
    Knoblich, Georgina
    Garcia, Cristina Cano
    Humke, Clara
    Preisser, Felix
    Traumann, Miriam
    Kluth, Luis A.
    Chun, Felix K. H.
    Mandel, Philipp
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [27] Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer
    Crawley, Danielle
    Garmo, Hans
    Rudman, Sarah
    Stattin, Par
    Zethelius, Bjorn
    Holmberg, Lars
    Adolfsson, Jan
    Van Hemelrijck, Mieke
    BJU INTERNATIONAL, 2018, 121 (02) : 209 - 216
  • [28] Extended pelvic lymphadenectomy in patients with clinically localised prostate cancer: A prospective observational study
    Ramos, J. G.
    Caicedo, J. I.
    Catano, J. G.
    Villarraga, L. G.
    Trujillo, C. G.
    Robledo, D.
    Plata, M.
    ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (07): : 446 - 452
  • [29] It is unclear whether pelvic lymphadenectomy is of oncological benefit in prostate cancer
    Weissbach, Lothar
    Roloff, Christiane
    AKTUELLE UROLOGIE, 2021, 52 (02) : 161 - 167
  • [30] Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review
    Laukhtina, Ekaterina
    Sari Motlagh, Reza
    Mori, Keiichiro
    Quhal, Fahad
    Schuettfort, Victor M.
    Mostafaei, Hadi
    Katayama, Satoshi
    Grossmann, Nico C.
    Ploussard, Guillaume
    Karakiewicz, Pierre I.
    Briganti, Alberto
    Abufaraj, Mohammad
    Enikeev, Dmitry
    Pradere, Benjamin
    Shariat, Shahrokh F.
    WORLD JOURNAL OF UROLOGY, 2021, 39 (11) : 4085 - 4099